In this episode, we talk about the importance of shared decision-making in helping patients achieve a “life of possibility”, especially in complex illnesses like multiple myeloma.
Our experts discuss the barriers that prevent patients and HCPs from being equal partners, how shared decision-making leads to better decision-making, and the critical role of advocacy groups in empowering patients to have a greater say in their treatment pathway.
This recording was organised and funded by Johnson & Johnson
August 2025
CP-530923 | CP-530918
","author_name":"Johnson & Johnson"}